N-(2-氯-6-甲基苯基)苯甲酰胺 | 10286-86-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: N-(2-氯-6-甲基苯基)苯甲酰胺
• 英文名称: N-(2-chloro-6-methylphenyl)benzamide
• 英文别名: N-benzoyl-2-chloro-6-methylaniline
• CAS: 10286-86-9
• 化学式: C₁₄H₁₂ClNO
• 分子量: 245.708
• InChiKey: KCMJCTKSNLUIOU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  17
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  29.1
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  N-(2-氯-6-甲基苯基)苯甲酰胺 在 正丁基锂 作用下， 以 四氢呋喃 、 正己烷 为溶剂， 生成 7-chloro-2-phenyl-1H-indole
  参考文献：
  名称：

  3-(4-Fluoropiperidin-3-yl)-2-phenylindoles as High Affinity, Selective, and Orally Bioavailable h5-HT_2A Receptor Antagonists

  摘要：

  The development of very high affinity, selective, and bioavailable h5-HT2A receptor antagonists is described. By investigation of the optimal position for the basic nitrogen in a series of 2-phenyl-3-piperidylindoles, it was found that with the basic nitrogen at the S-position of the piperidine it was not necessary to further substitute the piperidine in order to obtain good binding at h5-HT2A receptors. This meant the compounds no longer had high affinity at the IKr potassium channel, an issue with previous series of 2-aryl-3-(4-piperidyl)indoles. Improvements could be made to oral bioavailability in this series by reduction of the pK(a) of the basic nitrogen, by adding a fluorine atom to the piperidine ring, leading to 3-(4-fluoropiperidin-3-yl)-2-phenyl-1H-indole (17). Metabolic studies with this compound identified oxidation at the B-position of the indole as a major route in vitro and in vivo in rats. Blocking this position with a fluorine atom led to 6-fluoro-3-(4-fluoropiperidin-3-yl)-2-phenyl-1H-indole (22), an antagonist with 0.06 nM affinity for h5-HT2A receptors, with bioavailability of 80% and half-life of 12 h in rats.

  DOI：

  10.1021/jm0004998
• 作为产物：
  描述：

  甲基硝基苯 在 氯化亚砜 、 碳酸氢钠 、 氯化铵 、 锌 作用下， 以 乙醚 、 水 为溶剂， 反应 2.0h， 生成 N-(2-氯-6-甲基苯基)苯甲酰胺
  参考文献：
  名称：

  Ayyangar, N. R.; Kalkote, U. R.; Nikrad, P. V., Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 1983, vol. 22, # 9, p. 872 - 877

  摘要：

  DOI：

文献信息

• Exploiting the Reactivity of Isocyanide: Coupling Reaction between Isocyanide and Toluene Derivatives Using the Isocyano Group as an N1 Synthon
  作者：Zhiqiang Liu、Xinglu Zhang、Jianxiong Li、Feng Li、Chunju Li、Xueshun Jia、Jian Li

  DOI：10.1021/acs.orglett.6b01928

  日期：2016.8.19

  An unusual oxidative coupling reaction of isocyanide and toluene derivatives using tetrabutylammonium iodide (TBAI) as a catalyst is disclosed. The experimental results and mechanistic study show that the isocyano group acts formally as an N1 synthon during the transformation, thus expanding the reactivity profile of isocyanide.

  公开了使用碘化四丁铵（TBAI）作为催化剂的异氰酸酯和甲苯衍生物的不寻常的氧化偶联反应。实验结果和机理研究表明，异氰酸酯基团在转化过程中正式作为N1合成子起作用，从而扩大了异氰酸酯的反应活性。
• [EN] PYRROLO [2, 3-B] PYRIDINES OR PYRROLO [2, 3-B] PYRAZINES AS HPK1 INHIBITOR AND THE USE THEREOF<br/>[FR] PYRROLO [2, 3-B] PYRIDINES OU PYRROLO [2, 3-B] PYRAZINES COMME INHIBITEUR DE HPK1 ET LEUR UTILISATION
  申请人：BEIGENE LTD

  公开号：WO2019238067A1

  公开（公告）日：2019-12-19

  Disclosed herein is a compound of Formula (AIII) or (III), or a stereoisomer thereof, or a pharmaceutically acceptable salt thereof, and pharmaceutical compositions comprising thereof. Also disclosed is a method of treating HPK1 related disorders or diseases by using the compound disclosed herein.

  本文披露了一种公式（AIII）或（III）的化合物，或其立体异构体，或其药用可接受的盐，以及包含该化合物的药物组合物。还披露了一种利用本文披露的化合物治疗HPK1相关疾病或疾病的方法。
• Atroposelective Catalytic Asymmetric Allylic Alkylation Reaction for Axially Chiral Anilides with Achiral Morita–Baylis–Hillman Carbonates
  作者：Shou-Lei Li、Chen Yang、Quan Wu、Han-Liang Zheng、Xin Li、Jin-Pei Cheng

  DOI：10.1021/jacs.8b06014

  日期：2018.10.10

  A highly efficient method to access axially chiral anilides through asymmetric allylic alkylation reaction with achiral Morita-Baylis-Hillman carbonates by using a biscinchona alkaloid catalyst was reported. Through the atroposelective approach, a broad range of axially chiral anilide products with different acyl groups, such as substituted phenyl, naphthyl, alkyl, enyl, styryl, and benzyl, were generated

  报道了一种通过使用双金鸡纳生物碱催化剂与非手性 Morita-Baylis-Hillman 碳酸酯的不对称烯丙基烷基化反应获得轴向手性苯胺的高效方法。通过阻变选择性方法，以非常好的收率、中等至极好的顺式：反式比率生成了范围广泛的具有不同酰基的轴向手性苯胺产物，例如取代的苯基、萘基、烷基、烯基、苯乙烯基和苄基，以及良好的对映选择性。该反应可以放大，并且轴向手性苯胺的合成效用通过转化得到了证明。此外，引入线性自由能关系分析来研究反应。
• Synthesis and biological evaluation of novel 5(H)-phenanthridin-6-ones, 5(H)-phenanthridin-6-one diketo acid, and polycyclic aromatic diketo acid analogs as new HIV-1 integrase inhibitors
  作者：Shivaputra Patil、Shantaram Kamath、Tino Sanchez、Nouri Neamati、Raymond F. Schinazi、John K. Buolamwini

  DOI：10.1016/j.bmc.2006.11.026

  日期：2007.2.1

  A new series of phenanthridinone derivatives, and diketo acid analogs, as well as related phenanthrene and anthracene diketo acids have been synthesized and evaluated as HIV integrase (IN) inhibitors. Several new beta-diketo acid analogs with the phenanthridinone scaffold replaced by phenanthrene, anthracene or pyrene exhibited the highest IN inhibitory potency. There is a general selectivity against

  已经合成了一系列新的菲啶酮衍生物和二酮酸类似物，以及相关的菲和蒽二酮酸，并将其作为 HIV 整合酶 (IN) 抑制剂进行了评估。菲啶酮支架被菲、蒽或芘取代的几种新的 β-二酮酸类似物表现出最高的 IN 抑制效力。对整合酶链转移步骤有普遍的选择性。最有效的 IN 是 2,4-dioxo-4-phenanthren-9-yl-butyric acid (27f) 与 IC(50) 的 0.38microM 对整合酶链转移。菲二酮酸 27d-f 比相应的菲啶酮二酮酸 16 (IC(50)=65microM) 更有效 (IC(50)=2.7-0.38microM)，表明菲啶酮系统中的极性酰胺桥相对于更亲脂的菲系统降低了抑制活性。这可能与化合物的芳基可能结合到整合酶活性位点的亲脂口袋上，如对接模拟所建议的。分子模型还表明活性位点 Mg(2+) 螯合的有效性有助于 IN 抑制效力。最后，一些有效的化合物抑制
• Palladium-Catalyzed Synthesis of Benzimidazoles and Quinazolinones from Common Precursors
  作者：Jessie E. R. Sadig、Radleigh Foster、Florian Wakenhut、Michael C. Willis

  DOI：10.1021/jo301805d

  日期：2012.11.2

  utilized as complementary precursors for the synthesis of important heterocycles. The synthesis of N-substituted benzimidazoles was possible from the palladium-catalyzed reaction of both classes of substrate with a variety of N-nucleophiles. The use of the imidate precursor for the synthesis of N-substituted quinazolinones by incorporation of a palladium-catalyzed aminocarbonylation reaction has also been

  N-（邻卤代苯基）亚氨基酰氯和相应的酰亚胺化物易于制备，并且可用作合成重要杂环的互补前体。N-取代的苯并咪唑的合成可能是由两类底物与多种N-亲核试剂的钯催化反应所致。还已经证明了亚氨酸酯前体通过掺入钯催化的氨基羰基化反应用于合成N-取代的喹唑啉酮的用途。两种方法都可以耐受各种官能团。